Yogic Breathing Changes Salivary Components
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02108769|
Recruitment Status : Completed
First Posted : April 9, 2014
Last Update Posted : April 9, 2014
|Condition or disease||Intervention/treatment||Phase|
|Alzheimer Disease Neurodegenerative Diseases Cancer||Behavioral: Yogic Breathing Behavioral: Attention Control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Induction of Salivary Neuromodulators by Chanting and Breathing Exercise|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||November 2013|
|Actual Study Completion Date :||November 2013|
Experimental: Yogic Breathing
Behavioral: Yogic Breathing
Active Comparator: Attention Control
The participants will read a text of their choice for 20 minutes.
Behavioral: Attention Control
The participants will read a text of their choice for 20 minutes in a one-on-one session with the Yoga Instructor.
Other Name: Control
- Nerve growth factor quantification [ Time Frame: Three months from the date of sample collection ]Nerve growth factor will be quantified by ELISA and Western blotting.
- Measuring changes in salivary constituents [ Time Frame: 6 months from sample collection ]Western blotting, Multiplex ELISA and Lipidomic analysis will be conducted in saliva samples to determine changes in molecular constituents before and after study exercise.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02108769
|United States, South Carolina|
|Medical University of South Carolina|
|Charleston, South Carolina, United States, 29425|
|Principal Investigator:||Sundaravadivel Balasubramanian, PhD||Medical University of South Carolina|